Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Net Income towards Common Stockholders (2016 - 2020)

Historic Net Income towards Common Stockholders for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to -$878000.0.

  • Glucotrack's Net Income towards Common Stockholders fell 11370.63% to -$878000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was -$3.1 million, marking a year-over-year decrease of 18890.26%. This contributed to the annual value of $8.0 million for FY2023, which is N/A changed from last year.
  • Glucotrack's Net Income towards Common Stockholders amounted to -$878000.0 in Q4 2020, which was down 11370.63% from -$887000.0 recorded in Q3 2020.
  • Over the past 5 years, Glucotrack's Net Income towards Common Stockholders peaked at $18.5 million during Q4 2017, and registered a low of -$2.7 million during Q2 2017.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$995951.0 (2018), whereas its average is $376542.3.
  • As far as peak fluctuations go, Glucotrack's Net Income towards Common Stockholders skyrocketed by 149760.6% in 2017, and later plummeted by 15523.07% in 2019.
  • Over the past 5 years, Glucotrack's Net Income towards Common Stockholders (Quarter) stood at -$1.3 million in 2016, then soared by 1497.61% to $18.5 million in 2017, then plummeted by 105.48% to -$1.0 million in 2018, then soared by 733.34% to $6.4 million in 2019, then crashed by 113.71% to -$878000.0 in 2020.
  • Its Net Income towards Common Stockholders was -$878000.0 in Q4 2020, compared to -$887000.0 in Q3 2020 and -$611000.0 in Q2 2020.